Comparable outcomes of patients eligible vs ineligible for SWOG leukemia studies

Patients may be deemed ineligible for a clinical trial for reasons that do not directly impact efficacy or safety. We identified reasons for ineligibility and compared outcomes of ineligible with eligible patients treated on Southwest Oncology Group (SWOG) Leukemia Committee protocols. Patients enro...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Blood
Auteurs principaux: Statler, Abby, Othus, Megan, Erba, Harry P., Chauncey, Thomas R., Radich, Jerald P., Coutre, Steven, Advani, Anjali, Nand, Sucha, Ravandi, Farhad, Mukherjee, Sudipto, Sekeres, Mikkael A.
Format: Artigo
Langue:Inglês
Publié: American Society of Hematology 2018
Sujets:
Clinical Trials and Observations
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6014358/
https://ncbi.nlm.nih.gov/pubmed/29618479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-01-826693
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires